BioRexis Pharmaceutical Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

BioRexis Pharmaceutical General Information

Description

Producer of bio pharmaceuticals. The company offers protein and peptide drugs with pharmacology and Trans-bodies to replace conventional monoclonal antibodies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3400 Horizon Drive
  • King of Prussia, PA 19406
  • United States
+1 (610)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 3400 Horizon Drive
  • King of Prussia, PA 19406
  • United States
+1 (610)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioRexis Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Feb-2007 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Mar-2004 Completed Generating Revenue
1. Early Stage VC (Series A) 06-Jan-2003 $8M $8M Completed Product Development
To view BioRexis Pharmaceutical’s complete valuation and funding history, request access »

BioRexis Pharmaceutical Patents

BioRexis Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2007331195-A1 Transferrin fusion protein libraries Inactive 12-Dec-2006
CA-2673085-A1 Transferrin fusion protein libraries Active 12-Dec-2006
CA-2673085-C Transferrin fusion protein libraries Inactive 12-Dec-2006
EP-2114999-A2 Transferrin fusion protein libraries Pending 12-Dec-2006
EP-2479189-A1 Transferrin fusion protein libraries Active 12-Dec-2006 C07K14/705
To view BioRexis Pharmaceutical’s complete patent history, request access »

BioRexis Pharmaceutical Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anthem Capital Management Venture Capital Minority
Gund Investment Venture Capital Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Prism Venture Management Venture Capital Minority
ProQuest Investments Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

BioRexis Pharmaceutical FAQs

  • When was BioRexis Pharmaceutical founded?

    BioRexis Pharmaceutical was founded in 2002.

  • Where is BioRexis Pharmaceutical headquartered?

    BioRexis Pharmaceutical is headquartered in King of Prussia, PA.

  • What industry is BioRexis Pharmaceutical in?

    BioRexis Pharmaceutical’s primary industry is Drug Discovery.

  • Is BioRexis Pharmaceutical a private or public company?

    BioRexis Pharmaceutical is a Private company.

  • What is BioRexis Pharmaceutical’s current revenue?

    The current revenue for BioRexis Pharmaceutical is .

  • How much funding has BioRexis Pharmaceutical raised over time?

    BioRexis Pharmaceutical has raised $38M.

  • Who are BioRexis Pharmaceutical’s investors?

    Anthem Capital Management, Gund Investment, Johnson & Johnson JJDC, Prism Venture Management, and ProQuest Investments are 5 of 7 investors who have invested in BioRexis Pharmaceutical.

  • When was BioRexis Pharmaceutical acquired?

    BioRexis Pharmaceutical was acquired on 01-Feb-2007.

  • Who acquired BioRexis Pharmaceutical?

    BioRexis Pharmaceutical was acquired by Pfizer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process